1Li J T, Lu Y, Hou J, et al. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate - to - severe bacterial infections: results of a randomized, controlled clinical trial[J].Clin Infect Dis, 1997, 24 (3): 498.
2Oshida T, Oono Y, Toyoda M, et al. Efficacy of sulbactam/cefoperazone in respiratory tract infections in elderly patients with underlying respiratory diseases[J]. Jpn J Antibiot, 1996, 49(7):710.
4Dore M P,Graham D Y,Sepulveda A R,et al.Sensitivity of amoxicillin- resistant Helicobacter pylori to other penicillins[J]. Antimicrob Agents Chemother,1999,43(7):1803
5Schmalreck A F,Wildfeuer A.In vitro activity against clinically important gram- positive and gram- negative bacteria of sulbactam alone and in combination with ampicillin,cefotaxime,mezlocillin and piperacillin[J].Arzneimittelforschung,1990,40(10):1145
6Wildfeuer A,Schmalreck A,Rader K,et al.Studies on the synergism of sulbactam and β- lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration[J].Arzneimittelforschung,1989,39(1):94
7Bauernfeind A,Grimm H,Klietmann W,et al.The influence of sulbactam on the in vitro activity of mezlocillin,piperacillin and cefotaxime[J].Int J Antimicrob Agents,1996,6(1):S15
9Manncke K,Springsklee M,Heizmann W R,et al.Sulbactam in combination with mezlocillin,piperacillin or cefotaxime:clinical and bacteriological findings in the treatment of serious bacterial infections[J].Int J Antimicrob Agents,1996,6( 2) :S47
10Atsushi S,Tamai I,Kawazu K,et al.In vivo evidence for ATP-dependent and P-glycoprotein mediated tra_nsport of cyclosporin A at the blood brain barrier[].Biochemical Pharmacology.1994
